Brokerages Anticipate Sotera Health (NYSE:SHC) Will Post Earnings of $0.16 Per Share

Brokerages expect Sotera Health (NYSE:SHC) to post $0.16 earnings per share for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Sotera Health’s earnings, with the lowest EPS estimate coming in at $0.15 and the highest estimate coming in at $0.17. The firm is scheduled to announce its next quarterly earnings results on Tuesday, June 8th.

According to Zacks, analysts expect that Sotera Health will report full year earnings of $0.82 per share for the current year, with EPS estimates ranging from $0.80 to $0.83. For the next year, analysts anticipate that the business will post earnings of $0.99 per share, with EPS estimates ranging from $0.95 to $1.01. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Sotera Health.

Sotera Health (NYSE:SHC) last posted its quarterly earnings data on Monday, March 8th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.07 by $0.02. The firm had revenue of $216.90 million for the quarter, compared to analysts’ expectations of $212.29 million. The firm’s revenue for the quarter was up 12.1% compared to the same quarter last year.

SHC has been the subject of a number of recent analyst reports. Jefferies Financial Group initiated coverage on shares of Sotera Health in a research note on Tuesday, December 15th. They set a “buy” rating and a $33.50 target price for the company. Royal Bank of Canada initiated coverage on shares of Sotera Health in a research note on Tuesday, December 15th. They set an “outperform” rating and a $31.00 target price for the company. KeyCorp boosted their target price on shares of Sotera Health from $31.00 to $33.00 and gave the company an “overweight” rating in a research note on Tuesday, March 16th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research note on Tuesday, December 15th. They set a “buy” rating and a $34.00 target price for the company. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell started coverage on shares of Sotera Health in a research note on Tuesday, December 15th. They set a “buy” rating and a $32.00 target price for the company. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $32.32.

In other Sotera Health news, Director Pincus & Co. Warburg sold 13,512,582 shares of the business’s stock in a transaction dated Monday, March 22nd. The shares were sold at an average price of $26.12, for a total value of $352,948,641.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Matthew J. Klaben sold 41,952 shares of the business’s stock in a transaction dated Monday, March 22nd. The stock was sold at an average price of $26.12, for a total transaction of $1,095,786.24. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,371,973 shares of company stock valued at $375,395,935.

Institutional investors and hedge funds have recently bought and sold shares of the company. Citigroup Inc. acquired a new position in Sotera Health in the 4th quarter worth approximately $26,000. Ancora Advisors LLC acquired a new position in Sotera Health in the 4th quarter worth approximately $27,000. Victory Capital Management Inc. acquired a new position in Sotera Health in the 4th quarter worth approximately $217,000. Jane Street Group LLC acquired a new position in Sotera Health in the 4th quarter worth approximately $315,000. Finally, Boston Partners acquired a new position in Sotera Health in the 4th quarter worth approximately $409,000.

Shares of SHC traded up $0.07 during trading hours on Friday, reaching $26.02. 7,126 shares of the company traded hands, compared to its average volume of 1,382,204. Sotera Health has a 12-month low of $23.84 and a 12-month high of $30.38. The stock has a fifty day moving average of $26.41.

Sotera Health Company Profile

Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing.

Recommended Story: What’s a Black Swan?

Get a free copy of the Zacks research report on Sotera Health (SHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.